Uemura Kazunori, Kawada Toru, Zheng Can, Li Meihua, Sugimachi Masaru
Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, 565-8565, Japan.
BMC Anesthesiol. 2017 Oct 23;17(1):145. doi: 10.1186/s12871-017-0437-9.
Hemodynamic resuscitation in septic shock requires aggressive fluid replacement and appropriate use of vasopressors to optimize arterial pressure (AP) and cardiac output (CO). Because responses to these drugs vary between patients and within patient over time, strict monitoring of patient condition and repetitive adjustment of drug dose are required. This task is time and labor consuming, and is associated with poor adherence to resuscitation guidelines. To overcome this issue, we developed a computer-controlled closed-loop drug infusion system for automated hemodynamic resuscitation in septic shock, and evaluated the performance of the system in a canine model of endotoxin shock.
Our system monitors AP, CO and central venous pressure, and computes arterial resistance (R), stressed blood volume (V) and Frank-Starling slope of left ventricle (S). The system controls R with noradrenaline (NA), and V with Ringer's acetate solution (RiA), thereby controlling AP and CO. In 4 dogs, AP and CO were measured invasively. In another 4 dogs, AP and CO were measured less invasively using clinically acceptable modalities, aiming to make the system clinically feasible. In all 8 dogs, endotoxin shock was induced by injecting Escherichia coli lipopolysaccharide, which significantly decreased AP from 95 (91-108) to 43 (39-45) mmHg, and CO from 112 (104-142) to 62 (51-73) ml·min·kg. The system was then connected to the dogs, and activated. System performance was observed over a period of 4 h.
Our system immediately started infusions of NA and RiA. Within 40 min, RiA increased V to target level, and NA maintained R at target level, while S was concomitantly increased. These resulted in restoration of AP to 70 (69-71) mmHg and CO to 130 (125-138) ml·min·kg. Median of absolute performance error, an index of precision of control, was small in AP [2.5 (2.1-4.5) %] and CO [2.4 (1.4-5.5) %], which were not increased even when the variables were measured less invasively.
In a canine model of endotoxin shock, our system automatically improved and maintained AP and CO at their target values with small performance error. Our system is potentially an attractive clinical tool for rescuing patients with septic shock.
脓毒性休克的血流动力学复苏需要积极的液体复苏以及合理使用血管升压药,以优化动脉压(AP)和心输出量(CO)。由于患者对这些药物的反应随时间变化且因人而异,因此需要严格监测患者状况并反复调整药物剂量。这项任务既耗时又费力,而且与复苏指南的依从性差有关。为了克服这个问题,我们开发了一种计算机控制的闭环药物输注系统,用于脓毒性休克的自动血流动力学复苏,并在犬内毒素休克模型中评估了该系统的性能。
我们的系统监测AP、CO和中心静脉压,并计算动脉阻力(R)、应激血容量(V)和左心室的Frank-Starling斜率(S)。该系统用去甲肾上腺素(NA)控制R,用醋酸林格液(RiA)控制V,从而控制AP和CO。对4只犬进行有创AP和CO测量。对另外4只犬,使用临床可接受的方式进行无创AP和CO测量,以使该系统具有临床可行性。在所有8只犬中,通过注射大肠杆菌脂多糖诱导内毒素休克,使AP从95(91 - 108)mmHg显著降至43(39 - 45)mmHg,CO从112(104 - 142)ml·min·kg降至62(51 - 73)ml·min·kg。然后将该系统连接到犬身上并启动。观察系统性能4小时。
我们的系统立即开始输注NA和RiA。在40分钟内,RiA将V提高到目标水平,NA将R维持在目标水平,同时S随之增加。这些措施使AP恢复到70(69 - 71)mmHg,CO恢复到130(125 - 138)ml·min·kg。作为控制精度指标的绝对性能误差中位数在AP中较小[2.5(2.1 - 4.5)%],在CO中也较小[2.4(1.4 - 5.5)%],即使在采用无创测量变量时也未增加。
在犬内毒素休克模型中,我们的系统能自动将AP和CO改善并维持在目标值,且性能误差较小。我们的系统可能是抢救脓毒性休克患者的一种有吸引力的临床工具。